02-13 09:46 H.B. 500
1
Controlled Substance Modifications
2025 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Jennifer Dailey-Provost
Senate Sponsor:
2
3
LONG TITLE
4
General Description:
5
This bill amends provisions related to the Controlled Substances Act.
6
Highlighted Provisions:
7
This bill:
8
▸ classifies amanita muscaria as a controlled substance.
9
Money Appropriated in this Bill:
10
None
11
Other Special Clauses:
12
None
13
Utah Code Sections Affected:
14
AMENDS:
15
58-37-4, as last amended by Laws of Utah 2024, Chapter 298
16
17
Be it enacted by the Legislature of the state of Utah:
18
Section 1. Section 58-37-4 is amended to read:
19
58-37-4 . Schedules of controlled substances -- Schedules I through V -- Findings
20
required -- Specific substances included in schedules.
21
(1) There are established five schedules of controlled substances known as Schedules I, II,
22
III, IV, and V which consist of substances listed in this section.
23
(2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by the
24
official name, common or usual name, chemical name, or brand name designated:
25
(a) Schedule I:
26
(i) Unless specifically excepted or unless listed in another schedule, any of the
27
following opiates, including their isomers, esters, ethers, salts, and salts of
28
isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and
29
salts is possible within the specific chemical designation:
30
(A) Acetyl-alpha-methylfentanyl
H.B. 500 H.B. 500 02-13 09:46
31
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
32
(B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
33
(C) Acetylmethadol;
34
(D) Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);
35
(E) Allylprodine;
36
(F) Alphacetylmethadol, except levo-alphacetylmethadol also known as
37
levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
38
(G) Alphameprodine;
39
(H) Alphamethadol;
40
(I) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
41
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
42
(J) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
43
piperidinyl]-N-phenylpropanamide);
44
(K) Benzylpiperazine;
45
(L) Benzethidine;
46
(M) Betacetylmethadol;
47
(N) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
48
piperidinyl]-N-phenylpropanamide);
49
(O) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
50
phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
51
(P) Betameprodine;
52
(Q) Betamethadol;
53
(R) Betaprodine;
54
(S) Butyryl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);
55
(T) Clonitazene;
56
(U) Cyclopropyl fentanyl
57
(N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
58
(V) Dextromoramide;
59
(W) Diampromide;
60
(X) Diethylthiambutene;
61
(Y) Difenoxin;
62
(Z) Dimenoxadol;
63
(AA) Dimepheptanol;
64
(BB) Dimethylthiambutene;
- 2 - 02-13 09:46 H.B. 500
65
(CC) Dioxaphetyl butyrate;
66
(DD) Dipipanone;
67
(EE) Ethylmethylthiambutene;
68
(FF) Etizolam
69
(1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);
70
(GG) Etonitazene;
71
(HH) Etoxeridine;
72
(II) Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
73
furan-2-carboxamide);
74
(JJ) Furethidine;
75
(KK) Hydroxypethidine;
76
(LL) Ketobemidone;
77
(MM) Levomoramide;
78
(NN) Levophenacylmorphan;
79
(OO) Methoxyacetyl fentanyl
80
(2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);
81
(PP) Morpheridine;
82
(QQ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
83
(RR) Noracymethadol;
84
(SS) Norlevorphanol;
85
(TT) Normethadone;
86
(UU) Norpipanone;
87
(VV) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
88
propanamide);
89
(WW) Para-fluoroisobutyryl fentanyl
90
(N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
91
(XX) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
92
(YY) Phenadoxone;
93
(ZZ) Phenampromide;
94
(AAA) Phenomorphan;
95
(BBB) Phenoperidine;
96
(CCC) Piritramide;
97
(DDD) Proheptazine;
98
(EEE) Properidine;
- 3 - H.B. 500 02-13 09:46
99
(FFF) Propiram;
100
(GGG) Racemoramide;
101
(HHH) Tetrahydrofuran fentanyl
102
(N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
103
(III) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
104
(JJJ) Tilidine;
105
(KKK) Trimeperidine;
106
(LLL) 3-methylfentanyl, including the optical and geometric isomers
107
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);
108
(MMM) 3-methylthiofentanyl
109
(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
110
(NNN) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also
111
known as U-47700; and
112
(OOO) 4-cyano CUMYL-BUTINACA.
113
(ii) Unless specifically excepted or unless listed in another schedule, any of the
114
following opium derivatives, their salts, isomers, and salts of isomers when the
115
existence of the salts, isomers, and salts of isomers is possible within the specific
116
chemical designation:
117
(A) Acetorphine;
118
(B) Acetyldihydrocodeine;
119
(C) Benzylmorphine;
120
(D) Codeine methylbromide;
121
(E) Codeine-N-Oxide;
122
(F) Cyprenorphine;
123
(G) Desomorphine;
124
(H) Dihydromorphine;
125
(I) Drotebanol;
126
(J) Etorphine (except hydrochloride salt);
127
(K) Heroin;
128
(L) Hydromorphinol;
129
(M) Methyldesorphine;
130
(N) Methylhydromorphine;
131
(O) Morphine methylbromide;
132
(P) Morphine methylsulfonate;
- 4 - 02-13 09:46 H.B. 500
133
(Q) Morphine-N-Oxide;
134
(R) Myrophine;
135
(S) Nicocodeine;
136
(T) Nicomorphine;
137
(U) Normorphine;
138
(V) Pholcodine; and
139
(W) Thebacon.
140
(iii) Unless specifically excepted or unless listed in another schedule, any material,
141
compound, mixture, or preparation which contains any quantity of the following
142
hallucinogenic substances, or which contains any of their salts, isomers, and salts
143
of isomers when the existence of the salts, isomers, and salts of isomers is possible
144
within the specific chemical designation; as used in this Subsection (2)(a)(iii)
145
only, "isomer" includes the optical, position, and geometric isomers:
146
(A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase; α
147
-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;
148
(B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
149
4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
150
(C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
151
2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB;
152
2C-B, Nexus;
153
(D) 2,5-dimethoxyamphetamine, some trade or other names: 2,5-dimethoxy-α
154
-methylphenethylamine; 2,5-DMA;
155
(E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
156
(F) 4-methoxyamphetamine, some trade or other names: 4-methoxy-α
157
-methylphenethylamine; paramethoxyamphetamine, PMA;
158
(G) 5-methoxy-3,4-methylenedioxyamphetamine;
159
(H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
160
4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
161
(I) 3,4-methylenedioxy amphetamine;
162
(J) 3,4-methylenedioxymethamphetamine (MDMA);
163
(K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
164
alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE,
165
MDEA;
166
(L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
- 5 - H.B. 500 02-13 09:46
167
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy
168
MDA;
169
(M) 3,4,5-trimethoxy amphetamine;
170
(N) Bufotenine, some trade and other names: 3-(β
171
-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol;
172
N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
173
(O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
174
(P) Dimethyltryptamine, some trade or other names: DMT;
175
(Q) Ibogaine, some trade and other names: 7-Ethyl-6,6β
176
,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2]
177
azepino [5,4-b] indole; Tabernanthe iboga;
178
(R) Lysergic acid diethylamide;
179
(S) Marijuana;
180
(T) Mescaline;
181
(U) Parahexyl, some trade or other names:
182
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
183
Synhexyl;
184
(V) Peyote, meaning all parts of the plant presently classified botanically as
185
Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any
186
extract from any part of such plant, and every compound, manufacture, salts,
187
derivative, mixture, or preparation of such plant, its seeds or extracts
188
(Interprets 21 USC 812(c), Schedule I(c) (12));
189
(W) N-ethyl-3-piperidyl benzilate;
190
(X) N-methyl-3-piperidyl benzilate;
191
(Y) Psilocybin;
192
(Z) Psilocyn;
193
(AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
194
(cannabis plant), except for marijuana as defined in Subsection 58-37-2
195
(1)(aa)(i)(E), as well as synthetic equivalents of the substances contained in the
196
cannabis plant, or in the resinous extractives of Cannabis, sp. and/or synthetic
197
substances, derivatives, and their isomers with similar chemical structure and
198
pharmacological activity to those substances contained in the plant, such as the
199
following: Δ1 cis or trans tetrahydrocannabinol, and their optical isomers Δ6 cis or
200
trans tetrahydrocannabinol, and their optical isomers Δ3,4 cis or trans
- 6 - 02-13 09:46 H.B. 500
201
tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
202
substances is not internationally standardized, compounds of these structures,
203
regardless of numerical designation of atomic positions covered;
204
(BB) Ethylamine analog of phencyclidine, some trade or other names:
205
N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
206
N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
207
(CC) Pyrrolidine analog of phencyclidine, some trade or other names:
208
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
209
(DD) Thiophene analog of phencyclidine, some trade or other names:
210
1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine,
211
TPCP, TCP; and
212
(EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
213
(iv) Unless specifically excepted or unless listed in another schedule, any material
214
compound, mixture, or preparation which contains any quantity of the following
215
substances having a depressant effect on the central nervous system, including its
216
salts, isomers, and salts of isomers when the existence of the salts, isomers, and
217
salts of isomers is possible within the specific chemical designation:
218
(A) Mecloqualone; and
219
(B) Methaqualone.
220
(v) Any material, compound, mixture, or preparation containing any quantity of the
221
following substances having a stimulant effect on the central nervous system,
222
including their salts, isomers, and salts of isomers:
223
(A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline;
224
or 4,5-dihydro-5-phenyl-2-oxazolamine;
225
(B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
226
alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
227
(C) Fenethylline;
228
(D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
229
alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
230
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;
231
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432,
232
its salts, optical isomers, and salts of optical isomers;
233
(E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
234
(F) N-ethylamphetamine; and
- 7 - H.B. 500 02-13 09:46
235
(G) N,N-dimethylamphetamine, also known as
236
N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
237
(vi) Any material, compound, mixture, or preparation which contains any quantity of
238
the following substances, including their optical isomers, salts, and salts of
239
isomers, subject to temporary emergency scheduling:
240
(A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
241
(B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
242
(vii) Unless specifically excepted or unless listed in another schedule, any material,
243
compound, mixture, or preparation which contains any quantity of gamma
244
hydroxy butyrate (gamma hydrobutyric acid), including its salts, isomers, and
245
salts of isomers.
246
(b) Schedule II:
247
(i) Unless specifically excepted or unless listed in another schedule, any of the
248
following substances whether produced directly or indirectly by extraction from
249
substances of vegetable origin, or independently by means of chemical synthesis,
250
or by a combination of extraction and chemical synthesis:
251
(A) Opium and opiate, and any salt, compound, derivative, or preparation of
252
opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene,
253
naloxone, and naltrexone, and their respective salts, but including:
254
(I) Raw opium;
255
(II) Opium extracts;
256
(III) Opium fluid;
257
(IV) Powdered opium;
258
(V) Granulated opium;
259
(VI) Tincture of opium;
260
(VII) Codeine;
261
(VIII) Ethylmorphine;
262
(IX) Etorphine hydrochloride;
263
(X) Hydrocodone;
264
(XI) Hydromorphone;
265
(XII) Metopon;
266
(XIII) Morphine;
267
(XIV) Oxycodone;
268
(XV) Oxymorphone; and
- 8 - 02-13 09:46 H.B. 500
269
(XVI) Thebaine;
270
(B) Any salt, compound, derivative, or preparation which is chemically equivalent
271
or identical with any of the substances referred to in Subsection (2)(b)(i)(A),
272
except that these substances may not include the isoquinoline alkaloids of
273
opium;
274
(C) Opium poppy and poppy straw;
275
(D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves,
276
and any salt, compound, derivative, or preparation which is chemically
277
equivalent or identical with any of these substances, and includes cocaine and
278
ecgonine, their salts, isomers, derivatives, and salts of isomers and derivatives,
279
whether derived from the coca plant or synthetically produced, except the
280
substances may not include decocainized coca leaves or extraction of coca
281
leaves, which extractions do not contain cocaine or ecgonine; and
282
(E) Concentrate of poppy straw, which means the crude extract of poppy straw in
283
either liquid, solid, or powder form which contains the phenanthrene alkaloids
284
of the opium poppy.
285
(ii) Unless specifically excepted or unless listed in another schedule, any of the
286
following opiates, including their isomers, esters, ethers, salts, and salts of
287
isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and
288
salts is possible within the specific chemical designation, except dextrorphan and
289
levopropoxyphene:
290
(A) Alfentanil;
291
(B) Alphaprodine;
292
(C) Anileridine;
293
(D) Bezitramide;
294
(E) Bulk dextropropoxyphene (nondosage forms);
295
(F) Carfentanil;
296
(G) Dihydrocodeine;
297
(H) Diphenoxylate;
298
(I) Fentanyl;
299
(J) Isomethadone;
300
(K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
301
levomethadyl acetate, or LAAM;
302
(L) Levomethorphan;
- 9 - H.B. 500 02-13 09:46
303
(M) Levorphanol;
304
(N) Metazocine;
305
(O) Methadone;
306
(P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
307
(Q) Moramide-Intermediate, 2-methyl-3-morpholino-1,
308
1-diphenylpropane-carboxylic acid;
309
(R) Pethidine (meperidine);
310
(S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
311
(T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
312
(U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
313
(V) Phenazocine;
314
(W) Piminodine;
315
(X) Racemethorphan;
316
(Y) Racemorphan;
317
(Z) Remifentanil; and
318
(AA) Sufentanil.
319
(iii) Unless specifically excepted or unless listed in another schedule, any material,
320
compound, mixture, or preparation which contains any quantity of the following
321
substances having a stimulant effect on the central nervous system:
322
(A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
323
(B) Methamphetamine, its salts, isomers, and salts of its isomers;
324
(C) Phenmetrazine and its salts; and
325
(D) Methylphenidate.
326
(iv) Unless specifically excepted or unless listed in another schedule, any material,
327
compound, mixture, or preparation which contains any quantity of the following
328
substances having a depressant effect on the central nervous system, including its
329
salts, isomers, and salts of isomers when the existence of the salts, isomers, and
330
salts of isomers is possible within the specific chemical designation:
331
(A) Amobarbital;
332
(B) Glutethimide;
333
(C) Pentobarbital;
334
(D) Phencyclidine;
335
(E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
336
1-piperidinocyclohexanecarbonitrile (PCC); and
- 10 - 02-13 09:46 H.B. 500
337
(F) Secobarbital.
338
(v)(A) Unless specifically excepted or unless listed in another schedule, any
339
material, compound, mixture, or preparation which contains any quantity of
340
Phenylacetone.
341
(B) Some of these substances may be known by trade or other names:
342
phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
343
(vi) Nabilone, another name for nabilone: (±
344
)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
345
6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
346
(vii) A drug product or preparation that contains any component of marijuana,
347
including tetrahydrocannabinol, and is approved by the United States Food and
348
Drug Administration and scheduled by the Drug Enforcement Administration in
349
Schedule II of the federal Controlled Substances Act, Title II, P.L. 91-513.
350
(c) Schedule III:
351
(i) Unless specifically excepted or unless listed in another schedule, any material,
352
compound, mixture, or preparation which contains any quantity of the following
353
substances having a stimulant effect on the central nervous system, including its
354
salts, isomers whether optical, position, or geometric, and salts of the isomers
355
when the existence of the salts, isomers, and salts of isomers is possible within the
356
specific chemical designation:
357
(A) Those compounds, mixtures, or preparations in dosage unit form containing
358
any stimulant substances listed in Schedule II, which compounds, mixtures, or
359
preparations were listed on August 25, 1971, as excepted compounds under
360
Section 1308.32 of Title 21 of the Code of Federal Regulations, and any other
361
drug of the quantitive composition shown in that list for those drugs or which
362
is the same except that it contains a lesser quantity of controlled substances;
363
(B) Benzphetamine;
364
(C) Chlorphentermine;
365
(D) Clortermine; and
366
(E) Phendimetrazine.
367
(ii) Unless specifically excepted or unless listed in another schedule, any material,
368
compound, mixture, or preparation which contains any quantity of the following
369
substances having a depressant effect on the central nervous system:
370
(A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
- 11 - H.B. 500 02-13 09:46
371
pentobarbital, or any salt of any of them, and one or more other active
372
medicinal ingredients which are not listed in any schedule;
373
(B) Any suppository dosage form containing amobarbital, secobarbital, or
374
pentobarbital, or any salt of any of these drugs which is approved by the United
375
States Food and Drug Administration for marketing only as a suppository;
376
(C) Any substance which contains any quantity of a derivative of barbituric acid
377
or any salt of any of them;
378
(D) Chlorhexadol;
379
(E) Buprenorphine;
380
(F) Any drug product containing gamma hydroxybutyric acid, including its salts,
381
isomers, and salts of isomers, for which an application is approved under the
382
federal Food, Drug, and Cosmetic Act, Section 505;
383
(G) Ketamine, its salts, isomers, and salts of isomers, some other names for
384
ketamine: ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
385
(H) Lysergic acid;
386
(I) Lysergic acid amide;
387
(J) Methyprylon;
388
(K) Sulfondiethylmethane;
389
(L) Sulfonethylmethane;
390
(M) Sulfonmethane; and
391
(N) Tiletamine and zolazepam or any of their salts, some trade or other names for
392
a tiletamine-zolazepam combination product: Telazol, some trade or other
393
names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade
394
or other names for zolazepam:
395
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e]
396
[1,4]-diazepin-7(1H)-one, flupyrazapon.
397
(iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in
398
a U.S. Food and Drug Administration approved drug product, some other names
399
for dronabinol:
400
(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,
401
or (-)-delta-9-(trans)-tetrahydrocannabinol.
402
(iv) Nalorphine.
403
(v) Unless specifically excepted or unless listed in another schedule, any material,
404
compound, mixture, or preparation containing limited quantities of any of the
- 12 - 02-13 09:46 H.B. 500
405
following narcotic drugs, or their salts calculated as the free anhydrous base or
406
alkaloid:
407
(A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
408
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
409
alkaloid of opium;
410
(B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
411
milligrams per dosage unit, with one or more active non-narcotic ingredients in
412
recognized therapeutic amounts;
413
(C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
414
more than 15 milligrams per dosage unit, with a fourfold or greater quantity of
415
an isoquinoline alkaloid of opium;
416
(D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
417
more than 15 milligrams per dosage unit, with one or more active, non-narcotic
418
ingredients in recognized therapeutic amounts;
419
(E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more
420
than 90 milligrams per dosage unit, with one or more active non-narcotic
421
ingredients in recognized therapeutic amounts;
422
(F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
423
than 15 milligrams per dosage unit, with one or more active, non-narcotic
424
ingredients in recognized therapeutic amounts;
425
(G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams,
426
or not more than 25 milligrams per dosage unit, with one or more active,
427
non-narcotic ingredients in recognized therapeutic amounts; and
428
(H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams
429
with one or more active, non-narcotic ingredients in recognized therapeutic
430
amounts.
431
(vi) Unless specifically excepted or unless listed in another schedule, anabolic
432
steroids including any of the following or any isomer, ester, salt, or derivative of
433
the following that promotes muscle growth:
434
(A) Boldenone;
435
(B) Chlorotestosterone (4-chlortestosterone);
436
(C) Clostebol;
437
(D) Dehydrochlormethyltestosterone;
438
(E) Dihydrotestosterone (4-dihydrotestosterone);
- 13 - H.B. 500 02-13 09:46
439
(F) Drostanolone;
440
(G) Ethylestrenol;
441
(H) Fluoxymesterone;
442
(I) Formebulone (formebolone);
443
(J) Mesterolone;
444
(K) Methandienone;
445
(L) Methandranone;
446
(M) Methandriol;
447
(N) Methandrostenolone;
448
(O) Methenolone;
449
(P) Methyltestosterone;
450
(Q) Mibolerone;
451
(R) Nandrolone;
452
(S) Norethandrolone;
453
(T) Oxandrolone;
454
(U) Oxymesterone;
455
(V) Oxymetholone;
456
(W) Stanolone;
457
(X) Stanozolol;
458
(Y) Testolactone;
459
(Z) Testosterone; and
460
(AA) Trenbolone.
461
(vii) Anabolic steroids expressly intended for administration through implants to
462
cattle or other nonhuman species, and approved by the Secretary of Health and
463
Human Services for use, may not be classified as a controlled substance.
464
(viii) A drug product or preparation that contains any component of marijuana,
465
including tetrahydrocannabinol, and is approved by the United States Food and
466
Drug Administration and scheduled by the Drug Enforcement Administration in
467
Schedule III of the federal Controlled Substances Act, Title II, P.L. 91-513.
468
(ix) Nabiximols.
469
(x) Amanita Muscaria.
470
(d) Schedule IV:
471
(i) Unless specifically excepted or unless listed in another schedule, any material,
472
compound, mixture, or preparation containing not more than 1 milligram of
- 14 - 02-13 09:46 H.B. 500
473
difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or
474
any salts of any of them.
475
(ii) Unless specifically excepted or unless listed in another schedule, any material,
476
compound, mixture, or preparation which contains any quantity of the following
477
substances, including its salts, isomers, and salts of isomers when the existence of
478
the salts, isomers, and salts of isomers is possible within the specific chemical
479
designation:
480
(A) Alprazolam;
481
(B) Barbital;
482
(C) Bromazepam;
483
(D) Butorphanol;
484
(E) Camazepam;
485
(F) Carisoprodol;
486
(G) Chloral betaine;
487
(H) Chloral hydrate;
488
(I) Chlordiazepoxide;
489
(J) Clobazam;
490
(K) Clonazepam;
491
(L) Clorazepate;
492
(M) Clotiazepam;
493
(N) Cloxazolam;
494
(O) Delorazepam;
495
(P) Diazepam;
496
(Q) Dichloralphenazone;
497
(R) Estazolam;
498
(S) Ethchlorvynol;
499
(T) Ethinamate;
500
(U) Ethyl loflazepate;
501
(V) Fludiazepam;
502
(W) Flunitrazepam;
503
(X) Flurazepam;
504
(Y) Halazepam;
505
(Z) Haloxazolam;
506
(AA) Ketazolam;
- 15 - H.B. 500 02-13 09:46
507
(BB) Loprazolam;
508
(CC) Lorazepam;
509
(DD) Lormetazepam;
510
(EE) Mebutamate;
511
(FF) Medazepam;
512
(GG) Meprobamate;
513
(HH) Methohexital;
514
(II) Methylphenobarbital (mephobarbital);
515
(JJ) Midazolam;
516
(KK) Nimetazepam;
517
(LL) Nitrazepam;
518
(MM) Nordiazepam;
519
(NN) Oxazepam;
520
(OO) Oxazolam;
521
(PP) Paraldehyde;
522
(QQ) Pentazocine;
523
(RR) Petrichloral;
524
(SS) Phenobarbital;
525
(TT) Pinazepam;
526
(UU) Prazepam;
527
(VV) Quazepam;
528
(WW) Temazepam;
529
(XX) Tetrazepam;
530
(YY) Tramadol;
531
(ZZ) Triazolam;
532
(AAA) Zaleplon; and
533
(BBB) Zolpidem.
534
(iii) Any material, compound, mixture, or preparation of fenfluramine which contains
535
any quantity of the following substances, including its salts, isomers whether
536
optical, position, or geometric, and salts of the isomers when the existence of the
537
salts, isomers, and salts of isomers is possible.
538
(iv) Unless specifically excepted or unless listed in another schedule, any material,
539
compound, mixture, or preparation which contains any quantity of the following
540
substances having a stimulant effect on the central nervous system, including its
- 16 - 02-13 09:46 H.B. 500
541
salts, isomers whether optical, position, or geometric isomers, and salts of the
542
isomers when the existence of the salts, isomers, and salts of isomers is possible
543
within the specific chemical designation:
544
(A) Cathine ((+)-norpseudoephedrine);
545
(B) Diethylpropion;
546
(C) Fencamfamine;
547
(D) Fenproprex;
548
(E) Mazindol;
549
(F) Mefenorex;
550
(G) Modafinil;
551
(H) Pemoline, including organometallic complexes and chelates thereof;
552
(I) Phentermine;
553
(J) Pipradrol;
554
(K) Sibutramine; and
555
(L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
556
(v) Unless specifically excepted or unless listed in another schedule, any material,
557
compound, mixture, or preparation which contains any quantity of
558
dextropropoxyphene (alpha-(+)-4-dimethylamino-1,
559
2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
560
(vi) A drug product or preparation that contains any component of marijuana and is
561
approved by the United States Food and Drug Administration and scheduled by
562
the Drug Enforcement Administration in Schedule IV of the federal Controlled
563
Substances Act, Title II, P.L. 91-513.
564
(e) Schedule V:
565
(i) Any compound, mixture, or preparation containing any of the following limited
566
quantities of narcotic drugs, or their salts calculated as the free anhydrous base or
567
alkaloid, which includes one or more non-narcotic active medicinal ingredients in
568
sufficient proportion to confer upon the compound, mixture, or preparation
569
valuable medicinal qualities other than those possessed by the narcotic drug alone:
570
(A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
571
(B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
572
grams;
573
(C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
574
grams;
- 17 - H.B. 500 02-13 09:46
575
(D) not more than 2.5 milligrams of diphenoxylate and not less than 25
576
micrograms of atropine sulfate per dosage unit;
577
(E) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
578
(F) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
579
atropine sulfate per dosage unit; and
580
(G) unless specifically exempted or excluded or unless listed in another schedule,
581
any material, compound, mixture, or preparation which contains Pyrovalerone
582
having a stimulant effect on the central nervous system, including its salts,
583
isomers, and salts of isomers.
584
(ii) A drug product or preparation that contains any component of marijuana,
585
including cannabidiol, and is approved by the United States Food and Drug
586
Administration and scheduled by the Drug Enforcement Administration in
587
Schedule V of the federal Controlled Substances Act, Title II, P.L. 91-513.
588
(iii) Gabapentin.
589
Section 2. Effective Date.
590
This bill takes effect on May 7, 2025.
- 18 -